n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid has been researched along with Cancer of Prostate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brechbiel, MW; Davis, ID; Kelly, MP; Lee, FT; Lee, ST; Scott, AM; Smyth, FE | 1 |
| Alicke, B; Heitner, T; Lewis, JS; Light, DR; McLean, K; Parry, G; Parry, R; Satozawa, N; Schneider, DW; Yoo, J | 1 |
| Alicke, B; Biroc, S; Bringmann, P; Cobb, RR; Dinter, H; Halks-Miller, M; Harkins, R; Hudson, D; Klocker, H; Kretschmer, PJ; Larsen, B; Lewis, JS; Lin, R; Newton, A; Parkes, D; Parry, G; Parry, R; Roth, G; Schneider, D; Toy, P; Xuan, JA; Zhu, Y | 1 |
3 other study(ies) available for n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid and Cancer of Prostate
| Article | Year |
|---|---|
Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Radiation; Enzyme Inhibitors; ErbB Receptors; Humans; Isothiocyanates; Lutetium; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pentetic Acid; Phosphorylation; Prostatic Neoplasms; Quinazolines; Radiation-Sensitizing Agents; Radioimmunotherapy; Radioisotopes; Taxoids; Tyrphostins; Xenograft Model Antitumor Assays | 2009 |
In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Chelating Agents; Humans; Indium Radioisotopes; Isothiocyanates; Male; Mice; Mice, Nude; Neoplasm Transplantation; Pentetic Acid; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Transplantation, Heterologous; Yttrium Radioisotopes | 2009 |
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibody Specificity; Bone Neoplasms; CHO Cells; Cricetinae; Dose-Response Relationship, Immunologic; Extracellular Matrix Proteins; Humans; Immunotoxins; Isothiocyanates; Male; Molecular Sequence Data; Pentetic Acid; Positron-Emission Tomography; Prostatic Neoplasms; Radioimmunotherapy; RNA, Messenger; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2005 |